[Coomb's-positive hemolytic anemia and tuberculosis in Kaposi's sarcoma treated with interferon].

Abstract

Immune hemolytic anemia and reactivated tuberculosis developed in a patient treated with alpha-interferon for Kaposi's sarcoma and splenic non-Hodgkin's lymphoma. The hemolytic process stopped on cessation of interferon and initiation of corticosteroid therapy, and the Coomb's test became negative. The possibility of reactivation of tuberculosis by interferon is discussed.

• Authors: T Yermiahu, D Benharroch
• Journal: Harefuah (Harefuah) Vol. 127 Issue 11 Pg. 445-8, 503 (Dec 01 1994) ISSN: 0017-7768 [Print] Israel
• PMID: 7806102 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Interferon-alpha

Topics

• Aged
• Anemia, Hemolytic, Autoimmune (etiology)
• Coombs Test
• Female
• Humans
• Interferon-alpha (adverse effects, therapeutic use)
• Lymphoma, Non-Hodgkin (therapy)
• Recurrence
• Sarcoma, Kaposi (therapy)
• Splenic Neoplasms (therapy)
• Tuberculosis (complications)